African leaders accepted in the year 2001 through the Abuja Declaration to allocate 15% of
their government expenditure on health but by 2013 only five (5) African countries achieved …

Objective.—To develop consensus-based recommendations for the conduct of cost-
effectiveness analysis (CEA). This article, the second in a 3-part series, describes the basis …

The study aims to examine the potential relationship between public health expenditures,
logistics performance indices, renewable energy, and ecological sustainability in …

Background: Cost-effectiveness analysis is an important tool for informing treatment
coverage and pricing decisions, yet no consensus exists about what threshold for the …

We use linked administrative data that combines the universe of California birth records,
hospitalizations, and death records with parental income from Internal Revenue Service tax …

We describe research on the impact of health insurance on healthcare spending (“moral
hazard”), and use this context to illustrate the value of and important complementarities …

Abstract In 2011, Bristol-Myers Squibb set the price of its newly approved melanoma drug
ipilimumab—brand name Yervoy—at 120,000foracourseoftherapy.Thedrugwasassociatedwithanincrementalin …

We investigate whether physicians' financial incentives influence health care supply,
technology diffusion, and resulting patient outcomes. In 1997, Medicare consolidated the …

The US health care system is in crisis. At stake are the quality of care for millions of
Americans and the financial well-being of individuals and employers squeezed by …

The Economics of Health and Health Care is the market-leading health economics textbook,
providing comprehensive coverage of all the key topics, and balancing economic theory …